IVD Quality Control Market by Offering (Product [Serum, Blood, Urine-based], Data Management, Service), Technology (Biochemistry, Molecular, Immunoassay, Hematology), Application (Infectious Diseases, Oncology, Cardiology), and End User – Global Forecast to 2030
IVD Quality Control Market by Offering (Product [Serum, Blood, Urine-based], Data Management, Service), Technology (Biochemistry, Molecular, Immunoassay, Hematology), Application (Infectious Diseases, Oncology, Cardiology), and End User–Global Forecast to 2030
The IVD quality control market is expected to reach $2.19 billion by 2030, at a CAGR of 4.3% from 2023 to 2030.
After extensive primary and secondary research, the report provides an in-depth analysis of the IVD quality control market. The report also provides insights into the key drivers, restraints, challenges, and opportunities in the IVD quality control market. The growth of the IVD quality control market is driven by the rising prevalence of chronic diseases, coupled with the increasing geriatric population, growing demand for third-party quality controls, need for internal and external quality assessment reports, increasing number of clinical laboratories, growing demand for Point-of-Care (POC) and rapid diagnostics. However, stringent technical requirements and regulatory processes for quality controls restrain this market's growth.
The growing demand for multi-analyte and multi-instrument controls offers opportunities for market growth. However, the evolving regulatory landscape and lack of access to quality control/quality assurance materials are the major challenges to market growth.
Among the offering, in 2023, the quality control products segment is estimated to account for the largest share of the IVD quality control market. Increasing adoption of diagnostic products, demand for external quality assessment programs as these programs use quality controls in their programs, development of multi-analyte quality controls, new product launches, and increasing demand for independent controls contribute to the segments’ largest share.
Among the technologies, in 2023, the immunoassay/immunochemistry segment is estimated to account for the largest share of the IVD quality control market. The growing prevalence of chronic and infectious diseases and the increased adoption of immunoassay/immunochemistry tests, technological innovations in these tests, and the simultaneous development of quality control contributed to the segment's largest share.
Among the application, in 2023, the infectious diseases segment is estimated to account for the largest share of the IVD quality control market. The increasing prevalence of infectious diseases has led to the availability of a broad range of quality controls that are designed to monitor the assay precision of IVD tests for infectious diseases such as hepatitis, retrovirus, sexually transmitted diseases, congenital diseases, and other infectious diseases. According to the WHO, in 2020, there were an estimated 376 million new cases of sexually transmitted infections (STIs) worldwide, with chlamydia accounting for 129 million, gonorrhea for 82 million, syphilis for 7.1 million, and trichomoniasis for 156 million of the reported cases. The need for diagnosis of such infectious diseases also required quality controls for the quality assessment of tests, which further supported the largest share of the segment.
Among the end users, in 2023, the hospitals & clinics segment is estimated to account for the largest share of the IVD quality control market. The large segment share is majorly attributed to the large volume of diagnostics tests carried out in the hospitals, the rising prevalence of healthcare-associated infections (HAIs), increasing healthcare expenditure, and the rising number of hospitals and clinics across emerging markets.
An in-depth analysis of the geographical scenario of the IVD quality control market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is estimated to account for the largest share of the IVD quality control market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The high prevalence of chronic and infectious diseases, increasing awareness regarding early disease diagnosis, growing adoption of advanced diagnostic products, and increasing funding activities, coupled with novel developments in diagnostic technologies, are the factors supporting the largest share of this market.
The key players operating in the IVD quality control market are Seimens Healthineers AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), LGC Group (U.K.), Thermo Fisher Scientific Inc. (U.S.), SERO AS (Norway), Randox Laboratories Ltd. (U.K.), QuidelOrtho Corporation (U.S.), Streck LLC (U.S.), Microbiologics, Inc. (U.S.), and Bio-Techne Corporation (U.S.)
Scope of the Report:
IVD Quality Control Market Assessment—by Offering
IVD Quality Control Market Assessment—by Technology
IVD Quality Control Market Assessment—by Application
IVD Quality Control Market Assessment—by End User
IVD Quality Control Market Assessment—by Geography
The IVD quality control market is expected to reach $2.19 billion by 2030, at a CAGR of 4.3% from 2023 to 2030.
After extensive primary and secondary research, the report provides an in-depth analysis of the IVD quality control market. The report also provides insights into the key drivers, restraints, challenges, and opportunities in the IVD quality control market. The growth of the IVD quality control market is driven by the rising prevalence of chronic diseases, coupled with the increasing geriatric population, growing demand for third-party quality controls, need for internal and external quality assessment reports, increasing number of clinical laboratories, growing demand for Point-of-Care (POC) and rapid diagnostics. However, stringent technical requirements and regulatory processes for quality controls restrain this market's growth.
The growing demand for multi-analyte and multi-instrument controls offers opportunities for market growth. However, the evolving regulatory landscape and lack of access to quality control/quality assurance materials are the major challenges to market growth.
Among the offering, in 2023, the quality control products segment is estimated to account for the largest share of the IVD quality control market. Increasing adoption of diagnostic products, demand for external quality assessment programs as these programs use quality controls in their programs, development of multi-analyte quality controls, new product launches, and increasing demand for independent controls contribute to the segments’ largest share.
Among the technologies, in 2023, the immunoassay/immunochemistry segment is estimated to account for the largest share of the IVD quality control market. The growing prevalence of chronic and infectious diseases and the increased adoption of immunoassay/immunochemistry tests, technological innovations in these tests, and the simultaneous development of quality control contributed to the segment's largest share.
Among the application, in 2023, the infectious diseases segment is estimated to account for the largest share of the IVD quality control market. The increasing prevalence of infectious diseases has led to the availability of a broad range of quality controls that are designed to monitor the assay precision of IVD tests for infectious diseases such as hepatitis, retrovirus, sexually transmitted diseases, congenital diseases, and other infectious diseases. According to the WHO, in 2020, there were an estimated 376 million new cases of sexually transmitted infections (STIs) worldwide, with chlamydia accounting for 129 million, gonorrhea for 82 million, syphilis for 7.1 million, and trichomoniasis for 156 million of the reported cases. The need for diagnosis of such infectious diseases also required quality controls for the quality assessment of tests, which further supported the largest share of the segment.
Among the end users, in 2023, the hospitals & clinics segment is estimated to account for the largest share of the IVD quality control market. The large segment share is majorly attributed to the large volume of diagnostics tests carried out in the hospitals, the rising prevalence of healthcare-associated infections (HAIs), increasing healthcare expenditure, and the rising number of hospitals and clinics across emerging markets.
An in-depth analysis of the geographical scenario of the IVD quality control market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is estimated to account for the largest share of the IVD quality control market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The high prevalence of chronic and infectious diseases, increasing awareness regarding early disease diagnosis, growing adoption of advanced diagnostic products, and increasing funding activities, coupled with novel developments in diagnostic technologies, are the factors supporting the largest share of this market.
The key players operating in the IVD quality control market are Seimens Healthineers AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), LGC Group (U.K.), Thermo Fisher Scientific Inc. (U.S.), SERO AS (Norway), Randox Laboratories Ltd. (U.K.), QuidelOrtho Corporation (U.S.), Streck LLC (U.S.), Microbiologics, Inc. (U.S.), and Bio-Techne Corporation (U.S.)
Scope of the Report:
IVD Quality Control Market Assessment—by Offering
- Quality Control Products
- Quality Control Products, by Type
- Serum/Plasma-based Controls
- Whole Blood-based Controls
- Urine-based Controls
- Other Controls
- Quality Control Products, by Function
- Independent Controls
- Instrument-Specific Controls
- Quality Assessment Services
- Data Management Solutions
IVD Quality Control Market Assessment—by Technology
- Immunoassay/Immunochemistry
- Biochemistry/Clinical Chemistry
- Molecular Diagnostics
- Hematology
- Coagulation/Hemostasis
- Microbiology
- Other Technologies
IVD Quality Control Market Assessment—by Application
- Infectious Diseases
- Oncology
- Cardiology
- Autoimmune Disorders
- Neurology
- Other Applications
IVD Quality Control Market Assessment—by End User
- Hospitals & Clinics
- Diagnostic Laboratories
- Academic Institutes & Research Laboratories
- Other End Users
IVD Quality Control Market Assessment—by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
1. INTRODUCTION
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.2. Factor Analysis
4.3. Technology Trends
4.4. Regulatory Analysis
4.4.1. Regulations for IVD Products
4.4.1.1. North America
4.4.1.1.1. U.S.
4.4.1.1.2. Canada
4.4.1.2. Europe
4.4.1.3. Asia-Pacific
4.4.1.3.1. China
4.4.1.3.2. Japan
4.4.1.3.3. India
4.4.1.4. Latin America
4.4.1.5. Middle East & Africa
4.4.2. Regulations for Quality Management
4.4.2.1. North America
4.4.2.1.1. U.S.
4.4.2.1.2. Canada
4.4.2.2. Europe
4.4.2.2.1. Germany
4.4.2.2.2. France
4.4.2.2.3. U.K.
4.4.2.2.4. Italy
4.4.2.2.5. Spain
4.4.2.2.6. Rest of Europe (RoE)
4.4.2.3. Asia-Pacific
4.4.2.3.1. China
4.4.2.3.2. Japan
4.4.2.3.3. India
4.4.2.3.4. Rest of Asia-Pacific (RoAPAC)
4.4.2.4. Latin America
4.4.2.5. Middle East & Africa
4.5. Pricing Analysis
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Buyers
4.6.2. Bargaining Power of Suppliers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition
4.7. Associated Market Analysis: In Vitro Diagnostics (IVD) Market
5. IVD QUALITY CONTROL MARKET ASSESSMENT—BY OFFERING
5.1. Overview
5.2. Quality Control Products
5.2.1. Quality Control Products, by Type
5.2.1.1. Serum/Plasma-based Controls
5.2.1.2. Whole Blood-based Controls
5.2.1.3. Urine-based Controls
5.2.1.4. Other Controls
5.2.2. Quality Control Products, by Function
5.2.2.1. Independent Controls
5.2.2.2. Instrument-specific Controls
5.3. Quality Assessment Services
5.4. Data Management Solutions
6. IVD QUALITY CONTROL MARKET ASSESSMENT—BY TECHNOLOGY
6.1. Overview
6.2. Immunoassay/Immunochemistry
6.3. Biochemistry/Clinical Chemistry
6.4. Molecular Diagnostics
6.5. Hematology
6.6. Coagulation/Hemostasis
6.7. Microbiology
6.8. Other Technologies
7. GLOBAL IVD QUALITY CONTROL MARKET ASSESSMENT—BY APPLICATION
7.1. Overview
7.2. Infectious Diseases
7.3. Oncology
7.4. Cardiology
7.5. Autoimmune Disorders
7.6. Neurology
7.7. Other Applications
8. IVD QUALITY CONTROL MARKET ASSESSMENT—BY END USER
8.1. Overview
8.2. Hospitals & Clinics
8.3. Diagnostic Laboratories
8.4. Academic Institutes & Research Laboratories
8.5. Other End Users
9. IVD QUALITY CONTROL MARKET ASSESSMENT—BY GEOGRAPHY
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
9.6. Middle East & Africa
10. COMPETITION ANALYSIS
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
11. COMPANY PROFILES
11.1. Siemens Healthineers AG
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Product Portfolio
11.1.4. SWOT Analysis
11.2. Bio-Rad Laboratories, Inc.
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Product Portfolio
11.2.4. Strategic Developments
11.2.5. SWOT Analysis
11.3. Danaher Corporation
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Product Portfolio
11.3.4. SWOT Analysis
11.4. LGC Group
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Product Portfolio
11.4.4. Strategic Developments
11.4.5. SWOT Analysis
11.5. Thermo Fisher Scientific Inc.
11.5.1. Business Overview
11.5.2. Financial Overview
11.5.3. Product Portfolio
11.5.4. Strategic Developments
11.5.5. SWOT Analysis
11.6. Randox Laboratories Ltd.
11.6.1. Company Overview
11.6.2. Product Portfolio
11.6.3. Strategic Developments
11.6.4. SWOT Analysis
11.7. SERO AS
11.7.1. Company Overview
11.7.2. Product Portfolio
11.7.3. Strategic Developments
11.8. QuidelOrtho Corporation
11.8.1. Business Overview
11.8.2. Financial Overview
11.8.3. Product Portfolio
11.8.4. Strategic Developments
11.9. Streck LLC
11.9.1. Company Overview
11.9.2. Product Portfolio
11.9.3. Strategic Developments
11.10. Microbiologics, Inc.
11.10.1. Company Overview
11.10.2. Product Portfolio
11.10.3. Strategic Developments
11.11. Bio-Techne Corporation
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Product Portfolio
11.11.4. Strategic Developments
12. APPENDIX
12.1. Available Customization
12.2. Related Reports
Table 1 A Comparison Between the Characteristics of PBRTQC and Statistical IQC
Table 2 Regulatory Authorities Governing IVD Quality Controls, by Country/Region
Table 3 IVD Quality Control Product Pricing
Table 4 Global IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 5 Global Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 6 Global Quality Control Products Market, by Country/Region, 2021–2030 (USD Million)
Table 7 Global Serum/Plasma-Based Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Whole Blood-Based Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 9 Global Urine-Based Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 10 Global Other Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 12 Global Independent Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Instrument-Specific Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 14 Global Quality Assessment Services Market, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Data Management Solutions Market, by Country/Region, 2021–2030 (USD Million)
Table 16 Global IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 17 Global IVD Quality Control Market for Immunoassay/Immunochemistry, by Country/Region, 2021–2030 (USD Million)
Table 18 Global IVD Quality Control Market for Biochemistry/Clinical Chemistry, by Country/Region, 2021–2030 (USD Million)
Table 19 Global IVD Quality Control Market for Molecular Diagnostics, by Country/Region, 2021–2030 (USD Million)
Table 20 Global IVD Quality Control Market for Hematology, by Country/Region, 2021–2030 (USD Million)
Table 21 Global IVD Quality Control Market for Coagulation/Hemostasis, by Country/Region, 2021–2030 (USD Million)
Table 22 Global IVD Quality Control Market for Microbiology, by Country/Region, 2021–2030 (USD Million)
Table 23 Global IVD Quality Control Market for Other Technologies, by Country/Region, 2021–2030 (USD Million)
Table 24 Global IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 25 Global IVD Quality Control Market for Infectious Diseases, by Country/Region, 2021–2030 (USD Million)
Table 26 Increase in the Number of New Cancer Cases Globally (2020-2040)
Table 27 Global IVD Quality Control Market for Oncology, by Country/Region, 2021–2030 (USD Million)
Table 28 Global IVD Quality Control Market for Cardiology, by Country/Region, 2021–2030 (USD Million)
Table 29 Global IVD Quality Control Market for Autoimmune Disorders, by Country/Region, 2021–2030 (USD Million)
Table 30 Global IVD Quality Control Market for Neurology, by Country/Region, 2021–2030 (USD Million)
Table 31 Global IVD Quality Control Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 32 Global IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 33 Global IVD Quality Control Market for Hospitals & Clinics, by Country/Region, 2021–2030 (USD Million)
Table 34 Global IVD Quality Control Market for Diagnostic Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 35 Global IVD Quality Control Market for Academic Institutes & Research Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 36 Global IVD Quality Control Market for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 37 Global IVD Quality Control Market, by Country/Region, 2021–2030 (USD Million)
Table 38 North America: Estimated Cancer Cases, 2020–2030
Table 39 North America: IVD Quality Control Market, by Country, 2021–2030 (USD Million)
Table 40 North America: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 41 North America: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 42 North America: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 43 North America: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 44 North America: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 45 North America: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 46 U.S.: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 47 U.S.: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 48 U.S.: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 49 U.S.: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 50 U.S.: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 51 U.S.: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 52 Canada: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 53 Canada: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 54 Canada: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 55 Canada: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 56 Canada: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 57 Canada: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 58 Europe: IVD Quality Control Market, by Country/Region, 2021–2030 (USD Million)
Table 59 Europe: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 60 Europe: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 61 Europe: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 62 Europe: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 63 Europe: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 64 Europe: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 65 Germany: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 66 Germany: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 67 Germany: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 68 Germany: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 69 Germany: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 70 Germany: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 71 France: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 72 France: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 73 France: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 74 France: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 75 France: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 76 France: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 77 U.K.: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 78 U.K.: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 79 U.K.: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 80 U.K.: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 81 U.K.: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 82 U.K.: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 83 Italy: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 84 Italy: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 85 Italy: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 86 Italy: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 87 Italy: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 88 Italy: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 89 Spain: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 90 Spain: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 91 Spain: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 92 Spain: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 93 Spain: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 94 Spain: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 95 Rest of Europe: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 96 Rest of Europe: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 97 Rest of Europe: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 98 Rest of Europe: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 99 Rest of Europe: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 100 Rest of Europe: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 101 Asia-Pacific: IVD Quality Control Market, by Country/Region, 2021–2030 (USD Million)
Table 102 Asia-Pacific: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 103 Asia-Pacific: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 104 Asia-Pacific: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 105 Asia-Pacific: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 106 Asia-Pacific: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 107 Asia-Pacific: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 108 China: Mass Testing Drives to Control The Spread of Covid-19 Infections
Table 109 China: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 110 China: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 111 China: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 112 China: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 113 China: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 114 China: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 115 Japan: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 116 Japan: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 117 Japan: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 118 Japan: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 119 Japan: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 120 Japan: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 121 India: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 122 India: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 123 India: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 124 India: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 125 India: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 126 India: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 127 Rest of Asia-Pacific: Estimated Number of New Cancer Cases, by Country (2020–2030)
Table 128 Rest of Asia-Pacific: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 129 Rest of Asia-Pacific: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 130 Rest of Asia-Pacific: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 131 Rest of Asia-Pacific: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 132 Rest of Asia-Pacific: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 133 Rest of Asia-Pacific: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 134 Latin America: IVD Quality Control Market, by Country/Region, 2021–2030 (USD Million)
Table 135 Latin America: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 136 Latin America: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 137 Latin America: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 138 Latin America: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 139 Latin America: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 140 Latin America: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 141 Brazil: Testing Initiatives for COVID-19
Table 142 Brazil: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 143 Brazil: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 144 Brazil: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 145 Brazil: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 146 Brazil: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 147 Brazil: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 148 Mexico: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 149 Mexico: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 150 Mexico: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 151 Mexico: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 152 Mexico: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 153 Mexico: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 154 Rest of Latin America: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 155 Rest of Latin America: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 156 Rest of Latin America: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 157 Rest of Latin America: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 158 Rest of Latin America: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 159 Rest of Latin America: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 160 Middle East & Africa: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 161 Middle East & Africa: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 162 Middle East & Africa: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 163 Middle East & Africa: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 164 Middle East & Africa: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 165 Middle East & Africa: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 166 Recent Developments, by Company, 2020–2023
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.2. Factor Analysis
4.3. Technology Trends
4.4. Regulatory Analysis
4.4.1. Regulations for IVD Products
4.4.1.1. North America
4.4.1.1.1. U.S.
4.4.1.1.2. Canada
4.4.1.2. Europe
4.4.1.3. Asia-Pacific
4.4.1.3.1. China
4.4.1.3.2. Japan
4.4.1.3.3. India
4.4.1.4. Latin America
4.4.1.5. Middle East & Africa
4.4.2. Regulations for Quality Management
4.4.2.1. North America
4.4.2.1.1. U.S.
4.4.2.1.2. Canada
4.4.2.2. Europe
4.4.2.2.1. Germany
4.4.2.2.2. France
4.4.2.2.3. U.K.
4.4.2.2.4. Italy
4.4.2.2.5. Spain
4.4.2.2.6. Rest of Europe (RoE)
4.4.2.3. Asia-Pacific
4.4.2.3.1. China
4.4.2.3.2. Japan
4.4.2.3.3. India
4.4.2.3.4. Rest of Asia-Pacific (RoAPAC)
4.4.2.4. Latin America
4.4.2.5. Middle East & Africa
4.5. Pricing Analysis
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Buyers
4.6.2. Bargaining Power of Suppliers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition
4.7. Associated Market Analysis: In Vitro Diagnostics (IVD) Market
5. IVD QUALITY CONTROL MARKET ASSESSMENT—BY OFFERING
5.1. Overview
5.2. Quality Control Products
5.2.1. Quality Control Products, by Type
5.2.1.1. Serum/Plasma-based Controls
5.2.1.2. Whole Blood-based Controls
5.2.1.3. Urine-based Controls
5.2.1.4. Other Controls
5.2.2. Quality Control Products, by Function
5.2.2.1. Independent Controls
5.2.2.2. Instrument-specific Controls
5.3. Quality Assessment Services
5.4. Data Management Solutions
6. IVD QUALITY CONTROL MARKET ASSESSMENT—BY TECHNOLOGY
6.1. Overview
6.2. Immunoassay/Immunochemistry
6.3. Biochemistry/Clinical Chemistry
6.4. Molecular Diagnostics
6.5. Hematology
6.6. Coagulation/Hemostasis
6.7. Microbiology
6.8. Other Technologies
7. GLOBAL IVD QUALITY CONTROL MARKET ASSESSMENT—BY APPLICATION
7.1. Overview
7.2. Infectious Diseases
7.3. Oncology
7.4. Cardiology
7.5. Autoimmune Disorders
7.6. Neurology
7.7. Other Applications
8. IVD QUALITY CONTROL MARKET ASSESSMENT—BY END USER
8.1. Overview
8.2. Hospitals & Clinics
8.3. Diagnostic Laboratories
8.4. Academic Institutes & Research Laboratories
8.5. Other End Users
9. IVD QUALITY CONTROL MARKET ASSESSMENT—BY GEOGRAPHY
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
9.6. Middle East & Africa
10. COMPETITION ANALYSIS
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
11. COMPANY PROFILES
11.1. Siemens Healthineers AG
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Product Portfolio
11.1.4. SWOT Analysis
11.2. Bio-Rad Laboratories, Inc.
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Product Portfolio
11.2.4. Strategic Developments
11.2.5. SWOT Analysis
11.3. Danaher Corporation
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Product Portfolio
11.3.4. SWOT Analysis
11.4. LGC Group
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Product Portfolio
11.4.4. Strategic Developments
11.4.5. SWOT Analysis
11.5. Thermo Fisher Scientific Inc.
11.5.1. Business Overview
11.5.2. Financial Overview
11.5.3. Product Portfolio
11.5.4. Strategic Developments
11.5.5. SWOT Analysis
11.6. Randox Laboratories Ltd.
11.6.1. Company Overview
11.6.2. Product Portfolio
11.6.3. Strategic Developments
11.6.4. SWOT Analysis
11.7. SERO AS
11.7.1. Company Overview
11.7.2. Product Portfolio
11.7.3. Strategic Developments
11.8. QuidelOrtho Corporation
11.8.1. Business Overview
11.8.2. Financial Overview
11.8.3. Product Portfolio
11.8.4. Strategic Developments
11.9. Streck LLC
11.9.1. Company Overview
11.9.2. Product Portfolio
11.9.3. Strategic Developments
11.10. Microbiologics, Inc.
11.10.1. Company Overview
11.10.2. Product Portfolio
11.10.3. Strategic Developments
11.11. Bio-Techne Corporation
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Product Portfolio
11.11.4. Strategic Developments
12. APPENDIX
12.1. Available Customization
12.2. Related Reports
Table 1 A Comparison Between the Characteristics of PBRTQC and Statistical IQC
Table 2 Regulatory Authorities Governing IVD Quality Controls, by Country/Region
Table 3 IVD Quality Control Product Pricing
Table 4 Global IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 5 Global Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 6 Global Quality Control Products Market, by Country/Region, 2021–2030 (USD Million)
Table 7 Global Serum/Plasma-Based Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Whole Blood-Based Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 9 Global Urine-Based Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 10 Global Other Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 12 Global Independent Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Instrument-Specific Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 14 Global Quality Assessment Services Market, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Data Management Solutions Market, by Country/Region, 2021–2030 (USD Million)
Table 16 Global IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 17 Global IVD Quality Control Market for Immunoassay/Immunochemistry, by Country/Region, 2021–2030 (USD Million)
Table 18 Global IVD Quality Control Market for Biochemistry/Clinical Chemistry, by Country/Region, 2021–2030 (USD Million)
Table 19 Global IVD Quality Control Market for Molecular Diagnostics, by Country/Region, 2021–2030 (USD Million)
Table 20 Global IVD Quality Control Market for Hematology, by Country/Region, 2021–2030 (USD Million)
Table 21 Global IVD Quality Control Market for Coagulation/Hemostasis, by Country/Region, 2021–2030 (USD Million)
Table 22 Global IVD Quality Control Market for Microbiology, by Country/Region, 2021–2030 (USD Million)
Table 23 Global IVD Quality Control Market for Other Technologies, by Country/Region, 2021–2030 (USD Million)
Table 24 Global IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 25 Global IVD Quality Control Market for Infectious Diseases, by Country/Region, 2021–2030 (USD Million)
Table 26 Increase in the Number of New Cancer Cases Globally (2020-2040)
Table 27 Global IVD Quality Control Market for Oncology, by Country/Region, 2021–2030 (USD Million)
Table 28 Global IVD Quality Control Market for Cardiology, by Country/Region, 2021–2030 (USD Million)
Table 29 Global IVD Quality Control Market for Autoimmune Disorders, by Country/Region, 2021–2030 (USD Million)
Table 30 Global IVD Quality Control Market for Neurology, by Country/Region, 2021–2030 (USD Million)
Table 31 Global IVD Quality Control Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 32 Global IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 33 Global IVD Quality Control Market for Hospitals & Clinics, by Country/Region, 2021–2030 (USD Million)
Table 34 Global IVD Quality Control Market for Diagnostic Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 35 Global IVD Quality Control Market for Academic Institutes & Research Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 36 Global IVD Quality Control Market for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 37 Global IVD Quality Control Market, by Country/Region, 2021–2030 (USD Million)
Table 38 North America: Estimated Cancer Cases, 2020–2030
Table 39 North America: IVD Quality Control Market, by Country, 2021–2030 (USD Million)
Table 40 North America: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 41 North America: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 42 North America: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 43 North America: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 44 North America: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 45 North America: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 46 U.S.: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 47 U.S.: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 48 U.S.: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 49 U.S.: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 50 U.S.: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 51 U.S.: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 52 Canada: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 53 Canada: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 54 Canada: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 55 Canada: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 56 Canada: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 57 Canada: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 58 Europe: IVD Quality Control Market, by Country/Region, 2021–2030 (USD Million)
Table 59 Europe: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 60 Europe: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 61 Europe: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 62 Europe: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 63 Europe: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 64 Europe: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 65 Germany: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 66 Germany: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 67 Germany: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 68 Germany: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 69 Germany: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 70 Germany: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 71 France: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 72 France: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 73 France: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 74 France: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 75 France: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 76 France: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 77 U.K.: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 78 U.K.: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 79 U.K.: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 80 U.K.: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 81 U.K.: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 82 U.K.: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 83 Italy: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 84 Italy: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 85 Italy: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 86 Italy: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 87 Italy: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 88 Italy: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 89 Spain: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 90 Spain: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 91 Spain: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 92 Spain: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 93 Spain: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 94 Spain: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 95 Rest of Europe: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 96 Rest of Europe: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 97 Rest of Europe: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 98 Rest of Europe: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 99 Rest of Europe: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 100 Rest of Europe: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 101 Asia-Pacific: IVD Quality Control Market, by Country/Region, 2021–2030 (USD Million)
Table 102 Asia-Pacific: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 103 Asia-Pacific: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 104 Asia-Pacific: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 105 Asia-Pacific: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 106 Asia-Pacific: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 107 Asia-Pacific: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 108 China: Mass Testing Drives to Control The Spread of Covid-19 Infections
Table 109 China: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 110 China: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 111 China: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 112 China: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 113 China: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 114 China: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 115 Japan: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 116 Japan: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 117 Japan: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 118 Japan: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 119 Japan: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 120 Japan: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 121 India: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 122 India: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 123 India: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 124 India: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 125 India: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 126 India: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 127 Rest of Asia-Pacific: Estimated Number of New Cancer Cases, by Country (2020–2030)
Table 128 Rest of Asia-Pacific: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 129 Rest of Asia-Pacific: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 130 Rest of Asia-Pacific: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 131 Rest of Asia-Pacific: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 132 Rest of Asia-Pacific: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 133 Rest of Asia-Pacific: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 134 Latin America: IVD Quality Control Market, by Country/Region, 2021–2030 (USD Million)
Table 135 Latin America: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 136 Latin America: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 137 Latin America: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 138 Latin America: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 139 Latin America: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 140 Latin America: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 141 Brazil: Testing Initiatives for COVID-19
Table 142 Brazil: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 143 Brazil: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 144 Brazil: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 145 Brazil: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 146 Brazil: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 147 Brazil: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 148 Mexico: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 149 Mexico: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 150 Mexico: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 151 Mexico: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 152 Mexico: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 153 Mexico: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 154 Rest of Latin America: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 155 Rest of Latin America: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 156 Rest of Latin America: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 157 Rest of Latin America: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 158 Rest of Latin America: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 159 Rest of Latin America: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 160 Middle East & Africa: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 161 Middle East & Africa: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 162 Middle East & Africa: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 163 Middle East & Africa: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 164 Middle East & Africa: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 165 Middle East & Africa: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 166 Recent Developments, by Company, 2020–2023
